Summer programs host Biomaterials Day
The annual Biomaterials Day symposium took place on July 23, 2009 at the Madren Conference Center. The event was the seventh annual NIH-NSF Bioengineering and Bioinformatics Summer Institute (BBSI) and second annual NASA-REU symposium to feature speakers and student work.
In the morning, keynote speaker Dr. Tim Topoleski, a professor of mechanical engineering at the University of Maryland Baltimore County, presented on creativity and the human aspect of biomaterials research. Additionally, Dr. Niren Murthy, a professor of biomedical engineering at Georgia Institute of Technology presented new materials for treating and imaging inflammatory diseases, and Dr. Todd Purves, an urologist at Medical University of South Carolina, talked on an engineering approach to problems in urology from a clinician’s standpoint.
Throughout the day, participants in the BBSI and NASA-REU programs presented their summer work both orally and at poster sessions.
In 2003, Clemson was one of nine institutes selected by the NIH and NSF to host a pioneer summer institute program with the goal of introducing students across scientific disciplines to bioengineering and bioinformatics, with the ultimate goal of increasing the number of people who consider careers in these fields at the graduate level and beyond. This program targets undergraduate students who have completed their sophomore year and master’s degree candidates in their first two years of graduate study from institutions across the nation.
The NASA-REU program is funded by the South Carolina Space Grant Consortium and is in its second year of existence at Clemson. This nine-week summer program for South Carolina residents and students addresses biomedical problems of spaceflight mission specialists.
At the end of the day, presenters from Clemson and Poly-Med discussed bioengineering career options, and an awards ceremony recognized student work. The event was sponsored by the Society For Biomaterials, Poly-Med Inc., Selah Technologies LLC., and Zeus, Inc.